Complete Responses to Mitotane in Metastatic Adrenocortical Carcinoma—A New Look at an Old Drug

PURPOSE. Based largely on reports that predate modern reporting standards, mitotane has been considered a systemic treatment option for both hormone control and antitumor control of metastatic adrenocortical cancer (ACC), although the therapeutic window is narrow. METHODS. We searched electronic med...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncologist
Auteurs principaux: Reidy‐Lagunes, Diane L., Lung, Betty, Untch, Brian R., Raj, Nitya, Hrabovsky, Anastasia, Kelly, Ciara, Gerst, Scott, Katz, Seth, Kampel, Lewis, Chou, Joanne, Gopalan, Anu, Saltz, Leonard B.
Format: Artigo
Langue:Inglês
Publié: AlphaMed Press 2017
Sujets:
Endocrinology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5599197/
https://ncbi.nlm.nih.gov/pubmed/28559412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0459
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires